Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 248 clinical trials
featured
MBB102073: A clinical research study for subjects with Diabetes Mellitus, Type 2.

MBB102073: A clinical research study for subjects with Diabetes Mellitus, Type 2.

  • 28 views
  • 08 Nov, 2020
  • 1 location
featured
Clinical Trial to evaluate the safety and efficacy of a new medication in patients with Type II Diabetes with Inadequately Controlled Hypertension.

Clinical Trial to evaluate the safety and efficacy of a new medication in patients with Type II Diabetes with Inadequately Controlled Hypertension.

  • 230 views
  • 08 Nov, 2020
  • 1 location
featured
Marfan Syndrome (MFS) Medication Study

Marfan Syndrome (MFS) Medication Study

  • 88 views
  • 25 Mar, 2021
  • 1 location
Patiromer for the Management of Hyperkalemia in Subjects Receiving RAASi Medications for the Treatment of Heart Failure (DIAMOND)

The purpose of this study is to determine if patiromer treatment of subjects who developed hyperkalemia while receiving RAASi medications will result in continued use of RAASi medications in accordance with heart failure (HF) treatment guidelines and thereby decrease the occurrence of the combined endpoint of cardiovascular (CV) death and …

  • 37 views
  • 08 Jun, 2021
  • 485 locations
Twice Against Thrice-weekly Hemodialysis

Hemodialysis is the most worldwide prescribed renal replacement therapy for patients with end-stage renal disease. The frequency of sessions per week remains a debatable issue. In the majority of developed Western and Asian countries, patients on chronic hemodialysis are undergoing three dialysis sessions weekly. In developing countries and some developed …

renal replacement therapy
hypertension
chronic renal failure
chronic hemodialysis
  • 23 views
  • 26 Jan, 2021
  • 1 location
Pharmacodynamic Effects of Sacubitril/Valsartan on Natriuretic Peptides Angiotensin and Neprilysin

The study measure multiple neurohormones in patients with heart failure being treated with Sacubitril/Valsartan in increasing doses over an 8 week period.

ejection fraction
angiotensin
chronic heart failure
sacubitril/valsartan
  • 5 views
  • 23 Jan, 2021
  • 1 location
Effect of Angiotensin-Neprilysin Inhibition (ARNI) on Prognosis of Chronic Heart Failure

divided into Angiotensin-Neprilysin Inhibition (ARNI) group and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers (ACEI/ARB) group. All-cause death, cardiac death and re

angiotensin ii receptor antagonist
enalapril
nt-probnp
ace inhibitor
angiotensin
  • 0 views
  • 23 Jan, 2021
  • 1 location
Renin Angiotensin System Blockade in Renal Transplant Patients With Presence of PECs in Urine

By means of a personalized medicine strategy, investigators are going to evaluate if the treatment with an angiotensin II receptor antagonist (ARAII) in renal transplant patients with the

  • 0 views
  • 27 May, 2021
  • 1 location
Acute Haemodynamic Effects of Treatment With Angiotensin Converting Enzyme (ACE)-Inhibitors in Patients With Symptomatic Aortic Stenosis

Abundant evidence suggests that Angiotensin Converting Enzyme (ACE) inhibition potentially could reduce the hazardous effects of aortic stenosis and improve haemodynamics. The treatment

syncope
symptomatic aortic stenosis
angina pectoris
  • 0 views
  • 07 Nov, 2020
  • 1 location
Treatment of PH With Angiotensin II Receptor Blocker and Neprilysin Inhibitor in HFpEF Patients With CardioMEMS Device

This study will assess the impact of sacubitril/valsartan on elevated pulmonary artery (PA) pressures in patients with heart failure (HF) with preserved ejection fraction (HFpEF), measured using a previously implanted hemodynamic monitoring device (CardioMEMS).

  • 0 views
  • 24 Feb, 2021
  • 1 location